Galileo Research Facts No. 73: Does Galileo Therapy increase Creatine Kinase levels in Duchenne patients?
This pilot study tested the effects of Galileo Therapy on Creatine Kinase (CK) levels in children with Duchenne Muscle Dystrophy (DMD, Age 4-14). (Flexed legs, 13-20Hz, pos. 2, 2*2 min., 3/week, 4 weeks). Galileo Training did not show any significant increases in CK levels during the 4 weeks of Galileo Therapy. This study shows a relevant safety aspect of Galileo Therapy for DMD patients...